Rational development of FMN-based orthogonal riboswitch that functions in response to specific non-cognate ligand

Abstract Re-engineering natural riboswitches into orthogonal RNA switches by making them functional in response to exogenous ligands but unresponsive to endogenous cognate ligands is a promising yet less explored strategy for developing gene regulatory tools. Herein, we rationally engineer the aptam...

Full description

Saved in:
Bibliographic Details
Main Authors: Divya Ojha, Ambadas B. Rode
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-60722-4
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849334654073569280
author Divya Ojha
Ambadas B. Rode
author_facet Divya Ojha
Ambadas B. Rode
author_sort Divya Ojha
collection DOAJ
description Abstract Re-engineering natural riboswitches into orthogonal RNA switches by making them functional in response to exogenous ligands but unresponsive to endogenous cognate ligands is a promising yet less explored strategy for developing gene regulatory tools. Herein, we rationally engineer the aptamer domain of one of the largest and biotechnologically relevant flavin mononucleotide (FMN) riboswitch class, which specifically binds to synthetic ligands with a high binding affinity (K D  = ~ 54-75 nM) and regulates gene expression in vitro, in prokaryotic, and eukaryotic system, while being unresponsive to FMN. To develop the orthogonal aptamers, we rationally alter key tertiary interactions, such as A/G minor motifs and base triples located in the periphery of the FMN binding pocket. The biophysical and structural probing analysis of the orthogonal aptamer and synthetic ligand complex shows binding mediated by favorable enthalpic and unfavorable entropic contributions. Our rational design approach, coupled with the adaptability to FMN aptamers derived from diverse bacterial strains, suggests the broad applicability of this strategy to numerous FMN riboswitches, each possessing a unique expression platform. This will greatly expand the current repertoire of synthetic riboswitches available for biomedical applications.
format Article
id doaj-art-e589ac289dc54b79bb0b546a261819da
institution Kabale University
issn 2041-1723
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-e589ac289dc54b79bb0b546a261819da2025-08-20T03:45:31ZengNature PortfolioNature Communications2041-17232025-07-0116111610.1038/s41467-025-60722-4Rational development of FMN-based orthogonal riboswitch that functions in response to specific non-cognate ligandDivya Ojha0Ambadas B. Rode1Laboratory of Synthetic Biology, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurugram ExpresswayLaboratory of Synthetic Biology, Regional Centre for Biotechnology, NCR Biotech Science Cluster, 3rd Milestone, Faridabad-Gurugram ExpresswayAbstract Re-engineering natural riboswitches into orthogonal RNA switches by making them functional in response to exogenous ligands but unresponsive to endogenous cognate ligands is a promising yet less explored strategy for developing gene regulatory tools. Herein, we rationally engineer the aptamer domain of one of the largest and biotechnologically relevant flavin mononucleotide (FMN) riboswitch class, which specifically binds to synthetic ligands with a high binding affinity (K D  = ~ 54-75 nM) and regulates gene expression in vitro, in prokaryotic, and eukaryotic system, while being unresponsive to FMN. To develop the orthogonal aptamers, we rationally alter key tertiary interactions, such as A/G minor motifs and base triples located in the periphery of the FMN binding pocket. The biophysical and structural probing analysis of the orthogonal aptamer and synthetic ligand complex shows binding mediated by favorable enthalpic and unfavorable entropic contributions. Our rational design approach, coupled with the adaptability to FMN aptamers derived from diverse bacterial strains, suggests the broad applicability of this strategy to numerous FMN riboswitches, each possessing a unique expression platform. This will greatly expand the current repertoire of synthetic riboswitches available for biomedical applications.https://doi.org/10.1038/s41467-025-60722-4
spellingShingle Divya Ojha
Ambadas B. Rode
Rational development of FMN-based orthogonal riboswitch that functions in response to specific non-cognate ligand
Nature Communications
title Rational development of FMN-based orthogonal riboswitch that functions in response to specific non-cognate ligand
title_full Rational development of FMN-based orthogonal riboswitch that functions in response to specific non-cognate ligand
title_fullStr Rational development of FMN-based orthogonal riboswitch that functions in response to specific non-cognate ligand
title_full_unstemmed Rational development of FMN-based orthogonal riboswitch that functions in response to specific non-cognate ligand
title_short Rational development of FMN-based orthogonal riboswitch that functions in response to specific non-cognate ligand
title_sort rational development of fmn based orthogonal riboswitch that functions in response to specific non cognate ligand
url https://doi.org/10.1038/s41467-025-60722-4
work_keys_str_mv AT divyaojha rationaldevelopmentoffmnbasedorthogonalriboswitchthatfunctionsinresponsetospecificnoncognateligand
AT ambadasbrode rationaldevelopmentoffmnbasedorthogonalriboswitchthatfunctionsinresponsetospecificnoncognateligand